Literature DB >> 11606430

Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes.

M S Mahendroo1, K M Cala, D L Hess, D W Russell.   

Abstract

Mice lacking steroid 5 alpha-reductase 1 and 2 were produced by gene targeting and breeding. Male mice without 5 alpha-reductase 2 or without both enzymes had fully formed internal and external genitalia and were fertile, but had smaller prostates and seminal vesicles than controls. T accumulated to high levels in the reproductive tissues of the mutant mice. DHT administration increased seminal vesicle and coagulating gland weights in mice deficient in 5 alpha-reductase 2 and increased the weights of the prostate, seminal vesicle, and coagulating gland in animals deficient in both enzymes. An inhibitor of both 5 alpha-reductases (GI 208335X) decreased prostate and coagulating gland weights of control mice, but had no effect in those lacking 5 alpha-reductase 1 and 2. Castration reduced the sizes of these tissues in animals of all genotypes. Androgen-dependent gene expression was decreased in the seminal vesicles of mice lacking one or more 5 alpha-reductases and was restored by administration of T or DHT. Female mice missing both enzymes exhibited parturition and fecundity defects similar to those of animals without 5 alpha-reductase 1. We conclude that T is the only androgen required for differentiation of the male urogenital tract in mice and that the synthesis of DHT serves largely as a signal amplification mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606430      PMCID: PMC4446976          DOI: 10.1210/endo.142.11.8510

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  55 in total

1.  Genomic DNA microextraction: a method to screen numerous samples.

Authors:  R Ramírez-Solis; J Rivera-Pérez; J D Wallace; M Wims; H Zheng; A Bradley
Journal:  Anal Biochem       Date:  1992-03       Impact factor: 3.365

Review 2.  Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.

Authors:  G R Cunha; E T Alarid; T Turner; A A Donjacour; E L Boutin; B A Foster
Journal:  J Androl       Date:  1992 Nov-Dec

3.  Expression and regulation of steroid 5 alpha-reductase in the genital tubercle of the fetal rat.

Authors:  H Tian; D W Russell
Journal:  Dev Dyn       Date:  1997-05       Impact factor: 3.780

4.  Reversible decreases of fertility in male Sprague-Dawley rats treated orally with finasteride, a 5 alpha-reductase inhibitor.

Authors:  L D Wise; D H Minsker; M A Cukierski; R L Clark; S Prahalada; J M Antonello; J S MacDonald; R T Robertson
Journal:  Reprod Toxicol       Date:  1991       Impact factor: 3.143

5.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

Authors:  P C Walsh; J D Madden; M J Harrod; J L Goldstein; P C MacDonald; J D Wilson
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

6.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

7.  Testosterone formation and metabolism during male sexual differentiation in the human embryo.

Authors:  P K Siiteri; J D Wilson
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

8.  The dissociation of testosterone- and 5 alpha-dihydrotestosterone-receptor complexes formed within cultured human genital skin fibroblasts.

Authors:  M Kaufman; L Pinsky
Journal:  J Steroid Biochem       Date:  1983-02       Impact factor: 4.292

9.  Decreased 3 alpha-androstanediol glucuronide levels in plasma and random urines in male pseudohermaphroditism caused by 5 alpha-reductase deficiency.

Authors:  N H Ertel; S Akgun; E Samojlik; M A Kirschner; J Imperato-McGinley
Journal:  Metabolism       Date:  1989-09       Impact factor: 8.694

10.  The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase.

Authors:  J Imperato-McGinley; Z Binienda; A Arthur; D T Mininberg; E D Vaughan; F W Quimby
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

View more
  34 in total

1.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

2.  Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.

Authors:  Laura J Mosher; Roberto Cadeddu; Sabrina Yen; Jeffrey L Staudinger; Francesco Traccis; Stephen C Fowler; Jamie L Maguire; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2019-06-14       Impact factor: 4.905

Review 3.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

4.  Lucky, times ten: A career in Texas science.

Authors:  David W Russell
Journal:  J Biol Chem       Date:  2018-12-07       Impact factor: 5.157

5.  Effects of metoclopramide on mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats.

Authors:  Pilar Sánchez; Jesús M Torres; Beatriz Castro; José F Frías; Esperanza Ortega
Journal:  J Physiol Biochem       Date:  2012-07-18       Impact factor: 4.158

6.  Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain.

Authors:  Daisuke Matsui; Matomo Sakari; Takashi Sato; Akiko Murayama; Ichiro Takada; Misun Kim; Ken-ichi Takeyama; Shigeaki Kato
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

7.  Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.

Authors:  Shalender Bhasin; Thomas G Travison; Thomas W Storer; Kishore Lakshman; Manas Kaushik; Norman A Mazer; Ahn-Hoa Ngyuen; Maithili N Davda; Hernan Jara; Adam Aakil; Stephan Anderson; Philip E Knapp; Samson Hanka; Nurahmed Mohammed; Pierre Daou; Renee Miciek; Jagadish Ulloor; Anqi Zhang; Brad Brooks; Katie Orwoll; Leife Hede-Brierley; Richard Eder; Ayan Elmi; Geeta Bhasin; Lauren Collins; Ravinder Singh; Shehzad Basaria
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

8.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

Review 9.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

10.  Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5alpha-reductase mRNA isozymes in rat ventral prostate in different androgen status.

Authors:  Jesus M Torres; José A Gómez-Capilla; Estrella Ruiz; Esperanza Ortega
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.